Antilipolytic drugs for the prevention of primary ventricular fibrillation.

作者: Michael F. Oliver

DOI: 10.1046/J.1463-1326.2001.00147.X

关键词:

摘要:

参考文章(28)
V. A. KURIEN, P. A. YATES, M. F. OLIVER, The role of free fatty acids in the production of ventricular arrhythmias after acute coronary artery occlusion. European Journal of Clinical Investigation. ,vol. 1, pp. 225- 241 ,(1971) , 10.1111/ECI.1971.1.4.225
Alfred W. Stanley, Roger E. Moraski, Richard O. Russell, William J. Rogers, John A. Mantle, Robert A. Kreisberg, Huey G. McDaniel, Charles E. Rackley, Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. American Journal of Cardiology. ,vol. 36, pp. 929- 937 ,(1975) , 10.1016/0002-9149(75)90085-5
N.J Vetter, W Adams, R.C Strange, M.F Oliver, Initial metabolic and hormonal response to acute myocardial infarction. The Lancet. ,vol. 303, pp. 284- 289 ,(1974) , 10.1016/S0140-6736(74)92595-1
Roberto Ferrari, Patrizia Pepi, Federica Ferrari, Francesca Nesta, Massimo Benigno, Odoardo Visioli, None, Metabolic derangement in ischemic heart disease and its therapeutic control. American Journal of Cardiology. ,vol. 82, ,(1998) , 10.1016/S0002-9149(98)00531-1
Camillo Valori, Michael Thomas, John Shillingford, Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction American Journal of Cardiology. ,vol. 20, pp. 605- 617 ,(1967) , 10.1016/0002-9149(67)90001-X